Gleason Shane Thomas
SEC CIK 1966214 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NSPR | InspireMD, Inc. | VP Gbl Marketing | 1.05M | — | $288.8K | 7 | 2023-05-17 | 2026-01-15 |
Most active insiders at NSPR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stuka Paul | Dir | $283.9K | — |
| 2 | ROUBIN GARY S | Dir | $106.2K | — |
| 3 | Ward Scott R. | Dir | $102.6K | — |
| 4 | Gleason Shane Thomas | Chief Commercial Off | — | $99.2K |
| 5 | Slosman Marvin | CEO, Pres, Dir | $25.2K | — |
| 6 | Tommasoli Andrea | COO | — | — |
| 7 | Lawless Michael A | CFO | — | — |
| 8 | Arnold Kathryn | Dir | — | — |
| 9 | Dearen Danny L. | Dir | — | — |
| 10 | COHEN RAYMOND W | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-21 17:16 | 2025-01-27+ | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | S - Sale | $2.22 | -85.3K | 1.05M | -7% | -$189.6K |
| M | 2026-02-02 | 2026-01-15+ | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | S - Sale | $1.62 | -61.2K | 1.15M | -5% | -$99.2K |
| 2026-01-16 | 2026-01-14 | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +453.4K | 1.20M | +61% | $0 | |
| D | 2025-01-10 | 2025-01-07 | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +232.6K | 747.0K | +45% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +238.6K | 514.4K | +87% | $0 |
| D | 2023-08-30 | 2023-08-28 | NSPR | InspireMD, Inc. | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +19.3K | 275.7K | +8% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | InspireMD, Inc. | Gleason Shane Thomas | VP Gbl Marketing | A - Grant | $0.00 | +256.4K | 256.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations